Guggenheim Begins Coverage on Iterum Therapeutics (ITRM)

Share on StockTwits

Guggenheim assumed coverage on shares of Iterum Therapeutics (NASDAQ:ITRM) in a research report released on Tuesday morning. The brokerage issued a buy rating and a $21.00 target price on the stock.

Shares of NASDAQ ITRM opened at $12.00 on Tuesday. Iterum Therapeutics has a one year low of $11.23 and a one year high of $13.00.

In other news, CEO Corey N. Fishman acquired 3,000 shares of the firm’s stock in a transaction on Wednesday, May 30th. The shares were purchased at an average cost of $13.00 per share, with a total value of $39,000.00. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Patrick J. Heron acquired 456,099 shares of the firm’s stock in a transaction on Wednesday, May 30th. The stock was purchased at an average cost of $13.00 per share, for a total transaction of $5,929,287.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 965,099 shares of company stock worth $12,546,287.

About Iterum Therapeutics

There is no company description available for Iterum Therapeutics PLC.

Receive News & Ratings for Iterum Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iterum Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Analysts Anticipate Trade Desk Inc  Will Post Quarterly Sales of $103.67 Million
Analysts Anticipate Trade Desk Inc Will Post Quarterly Sales of $103.67 Million
Gap Inc  Expected to Announce Quarterly Sales of $3.98 Billion
Gap Inc Expected to Announce Quarterly Sales of $3.98 Billion
Sinovac Biotech  Given Daily Media Impact Rating of -0.02
Sinovac Biotech Given Daily Media Impact Rating of -0.02
Limoneira  Receives Daily News Sentiment Rating of 0.06
Limoneira Receives Daily News Sentiment Rating of 0.06
Motorola Solutions  Hits New 1-Year High at $121.69
Motorola Solutions Hits New 1-Year High at $121.69
Vince  Hits New 52-Week High at $20.35
Vince Hits New 52-Week High at $20.35


© 2006-2018 Ticker Report. Google+.